2m 2m 2m 2m 2m 2m 2m
Veracyte (VCYT)
NASDAQ
$53.80+$0.61 (+1.15%)
Price as of Jun 23, 2026 5:03 PM EDT- $4.2BMarket Cap
- 99.14%1-Year Change
- Diagnostics & ResearchIndustry
Veracyte (VCYT)
$53.80+$0.61 (+1.15%)
VCYT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $53.19 | ||
Change | -$0.44 (-0.82%) | ||
Open | $53.72 | ||
High | $54.72 | ||
Low | $52.36 | ||
Previous Close | $53.63 | ||
Volume | 967,185 | ||
30-Day Average Volume | 1,415,853 | ||
1-Week Change | 8.22% | ||
1-Month Change | 18.12% | ||
1-Year Change | 99.14% | ||
3-Year Change | 100.72% | ||
5-Year Change | 37.94% | ||
Fundamentals | |||
Shares Outstanding | 79.8M | ||
Total Assets | $1.4B | ||
Market Cap | $4.2B | ||
Enterprise Value | $4.0B | ||
Period: QTR TTM FY | |||
Revenue | $135.1M | ||
Net Income | $28.7M | ||
Free Cash Flow | $32.3M | ||
EBIT | $30.0M | ||
EBITDA | $35.4M | ||
Net Working Capital | $466.1M | ||
EPS | $0.35 | ||
Enterprise Value/EBITDA | 112 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 3 | ||
P/E | 152 | ||
PEG | -5 | ||
Price/Free Cash Flow | 132 | ||
Price/Operating Cash Flow | 121 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue